Ken O'Flynn
Ceist:315. Deputy Ken O'Flynn asked the Minister for Health whether the Health Service Executive has completed, or is in the process of completing, any National Centre for Pharmacoeconomics Rapid Review, Health Technology Assessment, or other formal evaluation for tirzepatide (mounjaro) and semaglutide (wegovy) for obesity or weight management; the date on which each assessment commenced; the current stage reached in each case; and the expected month in 2026 in which a pricing and reimbursement decision will be brought to the HSE senior leadership team. [10654/26]
Amharc ar fhreagra